Pediatrix Medical
211 hedge funds and large institutions have $1.39B invested in Pediatrix Medical in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 67 increasing their positions, 85 reducing their positions, and 20 closing their positions.
70% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 20
21% more call options, than puts
Call options by funds: $848K | Put options by funds: $701K
7% more funds holding
Funds holding: 198 → 211 (+13)
0.75% more ownership
Funds ownership: 99.13% → 99.88% (+0.75%)
21% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 85
23% less capital invested
Capital invested by funds: $1.82B → $1.39B (-$426M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$33.8M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$17.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$8.38M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$4.89M |
| 5 |
PC
Pavadi Capital
New York
|
+$3.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$61.8M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$15.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.7M |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$11.2M |
| 5 |
BlackRock
New York
|
-$8.18M |
MD Hedge Fund Activity: Q3 2022 in Review
211 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2022, worth a combined $1.39B — down 23% from $1.82B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new MD positions and 20 closed out — a net gain of 14 holders — while 67 added to existing stakes and 85 trimmed.
The largest buyer was Lazard Asset Management, adding an estimated $33.8M. The largest seller was Fidelity Investments, cutting an estimated $61.8M.
- 211 institutional investors held Pediatrix Medical (MD) as of Q3 2022, up from 198 in Q2 2022.
- Funds reported $1.39B of Pediatrix Medical stock for Q3 2022, down 23% quarter-over-quarter.
- 34 funds opened new Pediatrix Medical positions in Q3 2022 and 20 closed out, a net change of +14 holders.
- The largest Pediatrix Medical buyer in Q3 2022 was Lazard Asset Management, an estimated $33.8M added.
- The largest Pediatrix Medical seller in Q3 2022 was Fidelity Investments, an estimated $61.8M sold.
Based on aggregated 13F filings for Q3 2022.